{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:42:31Z","timestamp":1696221751839},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7298","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T22:43:09Z","timestamp":1340145789000},"page":"1579-1584","source":"Crossref","is-referenced-by-count":5,"title":["Isolated Isochromosome 17q in Myelodysplastic Syndromes with Pure Red Cell Aplasia and Basophilia"],"prefix":"10.2169","volume":"51","author":[{"given":"Yumiko","family":"Inui","sequence":"first","affiliation":[{"name":"Division of Medical Oncology\/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology\/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuo","family":"Okamura","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology\/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology\/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitake","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine and Medical Genetics, Department of Pathology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology\/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Minami","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology\/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1159\/000046636"},{"key":"2","unstructured":"2. Becher R, Carbonell F, Bartram CR. Isochromosome 17q in Ph<sup>1<\/sup>-negative leukemia: a clinical, cytogenetic, and molecular study. Blood 75: 1679-1683, 1990."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Weh HJ, Kuse R, Hossfeld DK. Acute nonlymphocytic leukemia (ANLL) with isochromosome i(17q) as the sole chromosomal anomaly: a distinct entity? Eur J Haematol 44: 312-314, 1990.","DOI":"10.1111\/j.1600-0609.1990.tb00401.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sol&eacute; F, Torrabadella M, Granada I, et al. Isochromosome 17q as a sole anomaly: a distinct myelodysplastic syndrome entity? Leuk Res 17: 717-720, 1993.","DOI":"10.1016\/0145-2126(93)90080-5"},{"key":"5","unstructured":"5. McClure RF, Dewald GW, Hoyer JD, Hanson CA. Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder\/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol 106: 445-454, 1999."},{"key":"6","unstructured":"6. Xiao Z, Liu S, Yu M, Xu Z, Hao Y. Isochromosome 17q in patients with myelodysplastic syndromes: six new cases. Haematologica 88: 714-715, 2003."},{"key":"7","unstructured":"7. Pinheiro RF, Chauffaille MLLF, Silva MRR. Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genet Cytogenet 166: 189-190, 2006."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nishida H, Ueno H, Park JW, Yano T. Isochromosome i(17q) as a sole cytogenetic abnormality in a case of leukemic transformation from myelodysplastic syndrome (MDS)\/myeloproliferative diseases (MPD). Leuk Res 32: 1325-1327, 2008.","DOI":"10.1016\/j.leukres.2007.11.021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Martinaud C, Pons S, M&eacute;nard G, Gisserot O, de Jaureguiberry JP, Brisou P. Myelodysplastic syndrome with erythroblastopenia. Rev Med Interne 32: 33-38, 2011 (in French, Abstract in English).","DOI":"10.1016\/j.revmed.2010.07.009"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<319::AID-AJH12>3.0.CO;2-2"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.44.5.431"},{"key":"12","unstructured":"12. Yokohama A, Murata N, Shimano S, et al. Myelodysplastic syndrome accompanied by i(17)(q10) anomaly following pure red cell aplasia and transient myeloproliferative stage. Rinsho Ketsueki. (Jpn J Clin Hematol.) 40: 34-39, 1999 (in Japanese, Abstract in English)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Park S, Merlat A, Guesnu M, et al. Pure red cell aplasia associated with myelodysplastic syndromes. Leukemia 14: 1709-1710, 2000.","DOI":"10.1038\/sj.leu.2401833"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shimamoto T, Iguchi T, Ando K, et al. Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. Br J Haematol 114: 358-361, 2001.","DOI":"10.1046\/j.1365-2141.2001.02925.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takata S, Kojima K, Fujii N, et al. Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22). Cancer Genet Cytogenet 140: 167-169, 2003.","DOI":"10.1016\/S0165-4608(02)00655-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Goyal R, Varma N, Marwaha RK. Myelodysplastic syndrome with erythroid hypoplasia. J Clin Pathol 58: 320-321, 2005.","DOI":"10.1136\/jcp.2004.020974"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Din&ccedil;ol G, &Ouml;zt&uuml;rk &Scedil;, Palanduz &Scedil;, et al. A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3;14)(p21.1;q24.1). Am J Hematol 81: 883-887, 2006.","DOI":"10.1002\/ajh.20684"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rawat S, Thakur R. Myelodysplasia with erythroid hypoplasia. Am J Hematol 81: 557-558, 2006.","DOI":"10.1002\/ajh.20660"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06648.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22. Bunn HF, McNeil BJ, Rosenthal DS, Krantz SB. Bone-marrow imaging in pure red blood cell aplasia. Arch Intern Med 136: 1169-1172, 1976.","DOI":"10.1001\/archinte.1976.03630100081021"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23. Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25: 3503-3510, 2007.","DOI":"10.1200\/JCO.2006.08.5696"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0947"},{"key":"23","doi-asserted-by":"crossref","unstructured":"25. Jary L, Mossafa H, Fourcade C, Genet P, Pilik M, Flandrin G. The 17p- syndrome: a distinct myelodysplastic syndrome entity? Leuk Lymphoma 25: 163-168, 1997.","DOI":"10.3109\/10428199709042506"},{"key":"24","doi-asserted-by":"crossref","unstructured":"26. Musilov&aacute; J, Michalov&aacute; K, Zemanov&aacute; Z, Brezinov&aacute; J. Multiple unrelated clones in myelodysplastic syndrome and in acute myeloid leukemia. Cancer Genet Cytogenet 88: 141-143, 1996.","DOI":"10.1016\/0165-4608(95)00289-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/12\/51_51.7298\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:43:52Z","timestamp":1621446232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/12\/51_51.7298\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7298","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}